Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Special Issue

KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025

Won Sohn, Young-Sun Lee, Soon Sun Kim, Jung Hee Kim, Young-Joo Jin, Gi-Ae Kim, Pil Soo Sung, Jeong-Ju Yoo, Young Chang, Eun Joo Lee, Hye Won Lee, Miyoung Choi, Su Jong Yu, Young Kul Jung, Byoung Kuk Jang, on behalf of The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2025;31(Suppl):S1-S31. Published online February 19, 2025

DOI: https://doi.org/10.3350/cmh.2025.0045

View: 600 Download: 95

Letter to the Editor

Forms of cholangitis to be considered after SARS-CoV-2 infection

Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim

Clin Mol Hepatol. 2022;28(4):929-930. Published online September 8, 2022

DOI: https://doi.org/10.3350/cmh.2022.0260

View: 3272 Download: 66 Web of Science: 2 Crossref: 3

Original Article

Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis

Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim, Joo Won Baik, Sun Young Yim, Young-Sun Lee, Yeon Seok Seo, Ji Hoon Kim, Jong Eun Yeon, Kwan Soo Byun

Clin Mol Hepatol. 2022;28(4):876-889. Published online September 19, 2022

DOI: https://doi.org/10.3350/cmh.2022.0231

View: 5300 Download: 140 Web of Science: 17 Crossref: 16

Review

Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases

Han Ah Lee, Young Chang, Pil Soo Sung, Eileen L. Yoon, Hye Won Lee, Jeong-Ju Yoo, Young-Sun Lee, Jihyun An, Do Seon Song, Young Youn Cho, Seung Up Kim, Yoon Jun Kim

Clin Mol Hepatol. 2022;28(3):425-472. Published online July 1, 2022

DOI: https://doi.org/10.3350/cmh.2022.0186

View: 9935 Download: 416 Web of Science: 15 Crossref: 17

Special Topic

Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline

Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim, on behalf of the Korean Association for the Study of the Liver

Clin Mol Hepatol. 2021;27(4):515-523. Published online September 17, 2021

DOI: https://doi.org/10.3350/cmh.2021.0293

View: 6755 Download: 91 Web of Science: 6 Crossref: 6

Original Article

Serum milk fat globule-EGF factor 8 protein as a potential biomarker for metabolic syndrome

Han Ah Lee, Jihwan Lim, Hyung Joon Joo, Young-Sun Lee, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Yoon Tae Jeen, Jong Eun Yeon, Do-Sun Lim, Kwan Soo Byun, Yeon Seok Seo

Clin Mol Hepatol. 2021;27(3):463-473. Published online February 15, 2021

DOI: https://doi.org/10.3350/cmh.2020.0351

View: 6652 Download: 176 Web of Science: 4 Crossref: 4

Special Topic

Management of liver diseases during the pandemic of coronavirus disease-19

Ju-Yeon Cho, Soon Sun Kim, Young-Sun Lee, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim, Korean Association for the Study of the Liver

Clin Mol Hepatol. 2020;26(3):243-250. Published online June 23, 2020

DOI: https://doi.org/10.3350/cmh.2020.0111

View: 8112 Download: 242 Web of Science: 8 Crossref: 7

Case Report

Complete response of advanced hepatocellular carcinoma to sorafenib : another case and a comprehensive review

Tae Suk Kim, Ji Hoon Kim, Baek hui Kim, Young-Sun Lee, Yang Jae Yoo, Seong Hee Kang, Sang-June Suh, Young Kul Jung, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun

Clin Mol Hepatol. 2017;23(4):340-346. Published online June 20, 2017

DOI: https://doi.org/10.3350/cmh.2016.0070

View: 17126 Download: 201 Web of Science: 19 Crossref: 19

1 |

Viewed By 7079	MAFLD: How is it different from NAFLD?
Viewed By 6456	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 5387	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 5200	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4705	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 298	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 266	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 181	MAFLD: How is it different from NAFLD?
Cited By 92	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 88	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search